Summary of the France Biotech expertise group
Access to healthcare data is a critical issue for research and innovation. Yet, as revealed by France Biotech revealed, a paradox persists: healthcare establishments produce the most strategic data, but access to it remains limited to the players who need it most, thus holding back innovation.
As a member of France Biotech's "Usage de la Donnée de Santé" task force, ADLIN Science contributed to this mapping of healthcare data needs and uses, carried out among 150 players (hospitals, biotechs, medtechs). This initiative aims to :